NCT00528099View on ClinicalTrials.gov

Study Evaluating IMA-026 in Healthy Japanese Males

PHASE1CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

November 30, 2008

Study Completion Date

November 30, 2008

Conditions
Healthy
Interventions
DRUG

IMA-026

SC and IV ascending single doses from lyophilized dosage form 0.3, 1, 2, 4 mg/kg SC and 3 mg/kg IV

Trial Locations (1)

171-0014

Toshima-ku

All Listed Sponsors
lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00528099 - Study Evaluating IMA-026 in Healthy Japanese Males | Biotech Hunter | Biotech Hunter